P2, N=50, Not yet recruiting, 3D Medicines (Beijing) Co., Ltd. | Trial completion date: Jun 2024 --> Jun 2026 | Trial primary completion date: Dec 2023 --> Dec 2025
7 months ago
Trial completion date • Trial primary completion date • Metastases
P2, N=50, Not yet recruiting, 3D Medicines (Beijing) Co., Ltd. | Trial completion date: Dec 2026 --> Jun 2024 | Trial primary completion date: Dec 2026 --> Dec 2023
1 year ago
Trial completion date • Trial primary completion date • Metastases